Abstract
Purposes
To compare hearing recovery levels after initial treatment or salvage intratympanic dexamethasone injection (ITDI), and to find the prognostic factor on salvage ITDI therapy in profound ISSNHL.
Methods
We retrospectively reviewed 115 patients with profound ISSNHL. All patients were treated with combination or systemic steroid therapy as the initial treatment. Next, we used salvage ITDI therapy on patients who showed slight or no improvement according to Siegel’s criteria. To find the prognostic factors for the effectiveness of salvage ITDI therapy, we analyzed clinical data, such as, age, sex, vertigo, symptom duration, diabetes, hypertension, initial PTA, pre-salvage PTA, and treatment methods, using multiple regression analyses.
Results
The rate of serviceable hearing recovery were 10.4% (12/115) in the initial-treatment group and 20.4% (21/103) in the salvage group. The difference was statistically significant (p = 0.041). Pre-salvage PTA, diabetes mellitus, and symptom duration were affective factors for the effectiveness of salvage ITDI therapy in profound ISSNHL refractory to initial treatment, with odds ratios of 1.169 (95% confidence interval, 1.088–1.256), 0.069 (95% confidence interval, 0.005–0.889), and 9.242 (95% confidence interval, 1.079–79.146).
Conclusions
Salvage therapy should be considered for profound ISSNHL, which is expected to result in poor prognosis or hearing recovery: ITSI therapy might be an effective treatment as salvage therapy.
Similar content being viewed by others
References
Fetterman BL, Saunders JE, Luxford WM (1996) Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 17:529–536
Battaglia A, Burchette R, Cueva R (2008) Combination therapy (intratympanic dexamethasone [3] high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 29:453–460. https://doi.org/10.1097/MAO.0b013e318168da7a
Ciuffetti G, Scardazza A, Serafini G, Lombardini R, Mannarino E, Simoncelli C (1991) Whole-blood filterability in sudden deafness. Laryngoscope 101:65–67
Gianoli GJ, Li JC (2001) Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 125(3):142–146
Hunchaisri N, Chantapant S, Srinangyam N (2010) Intratympanic dexamethasone for refractory sudden sensorineural hearing loss. J Med Assoc Thail 93(12):1406–1414
Edizer DT, Çelebi Ö, Hamit B, Baki A, Yiğit Ö (2015) Recovery of idiopathic sudden sensorineural hearing loss. J Int Adv Otol 11(2):122–126. https://doi.org/10.5152/iao.2015.1227
Giannoni B, Pagnini P, Vannucchi P (1998) Delayed endolymphatic hydrops. Acta Otorhinolaryngol Ital 18(4 Suppl 59):66–70
Filipo R, Attanasio G, Russo FY, Cartocci G, Musacchio A, De Carlo A, Roukos R, De Seta E, Di Tillo G, Viccaro M, Sarnacchiaro P, Covelli E (2014) Oral versus short-term intratympanic prednisolone therapy for idiopathic sudden hearing loss. Audiol Neurootol 19(4):225–233. https://doi.org/10.1159/000360069
Hong SM, Ko YG, Park CH, Lee JH, Kim JH (2012) Analysis of hearing improvement in patients with severe to profound sudden sensorineural hearing loss according to the level of pure tone hearing threshold. Eur Arch Otorhinolaryngol 269:2057–2060. https://doi.org/10.1007/s00405-011-1864-1868
Battaglia A, Lualhati A, Lin H, Burchette R, Cueva R (2014) A prospective, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high-dose prednisone alone: a 139 patient follow-up. Otol Neurotol 35(6):1091–1098. https://doi.org/10.1097/MAO.0000000000000450
Arastou S, Tajedini A, Borghei P (2013) Combined intratympanic and systemic steroid therapy for poor-prognosis sudden sensorineural hearing loss. Iran J Otorhinolaryngol 25(70):23–28
Lim HJ, Kim YT, Choi SJ, Lee JB, Park HY, Park K, Choung YH (2013) Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial. Otolaryngol Head Neck Surg 148(1):121–127. https://doi.org/10.1177/0194599812464475
Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I (1996) Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 75:468–471
Lee HS, Kim JM, Kim YJ, Chung DH, Seo BS, Kim SH (2008) Results of intratympanic dexamethasone therapy as salvage treatment in idiopathic sudden hearing loss. J Otolaryngol Head Neck Surg 37:263–268
Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH (2008) Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 128:128–131
Choung YH, Park K, Shin YR, Cho MJ (2006) Intratympanic dexamethasone therapy for refractory sudden sensorineural hearing loss. Laryngoscope 116:747–752
Fu Y, Zhao H, Zhang T, Chi F (2011) Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: clinical evaluation and laboratory investigation. Auris Nasus Larynx 38(2):165–171. https://doi.org/10.1016/j.anl.2010.07.008
Siegel LG (1975) The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 8:467–473
Chang NC, Ho KY, Kuo WR (2005) Audiometric patterns and prognosis in sudden sensorineural hearing loss in southern Taiwan. Otolaryngol Head Neck Surg 133:916–922
Wen YH, Chen PR, Wu HP (2014) Prognostic factors of profound idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 271:1423–1429. https://doi.org/10.1007/s00405-013-2593-y
Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD (2011) Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 145:1016–1021. https://doi.org/10.1177/0194599811418169
Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH (2011) The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 268:833–839. https://doi.org/10.1007/s00405-010-1476-8
Li P, Zeng XL, Ye J, Yang QT, Zhang GH, Li Y (2011) Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol Neurootol 16(3):198–202. https://doi.org/10.1159/000320838
Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR (2011) Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol 32:774–779. https://doi.org/10.1097/MAO.0b013e31821fbdd1
Crane RA, Camilon M, Nguyen S, Meyer TA (2015) Steroids for treatment of sudden sensorineural hearing loss: a metaanalysis of randomized controlled trials. Laryngoscope 125:209–217. https://doi.org/10.1002/lary.24834
Garavello W, Galluzzi F, Gaini RM, Zanetti D (2012) Intratympanic steroid treatment for sudden deafness: a metaanalysis of randomized controlled trials. Otol Neurotol 33:724–729. https://doi.org/10.1097/MAO.0b013e318254ee04
Barreto MA, Ledesma AL, de Oliveira CA, Bahmad F Jr (2016) Intratympanic corticosteroid for sudden hearing loss: does it really work? Braz J Otorhinolaryngol 82(3):353–364. https://doi.org/10.1016/j.bjorl.2015.06.007
Li H, Feng G, Wang H, Feng Y (2015) Intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss after failure of conventional therapy: a meta-analysis of randomized, controlled trials. Clin Ther 37:178–187. https://doi.org/10.1016/j.clinthera.2014.11.009
Ng JH, Ho RC, Cheong CS, Ng A, Yuen HW, Ngo RY (2015) Intratympanic steroids as a salvage treatment for sudden sensorineural hearing loss? A meta-analysis. Eur Arch Otorhinolaryngol 272:2777–2782. https://doi.org/10.1007/s00405-014-3288-8
Spear SA, Schwartz SR (2011) Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 145:534–543. https://doi.org/10.1177/0194599811419466
Covelli E, Altabaa K, Verillaud B, Camous D, Hautefort C, Barbara M, Herman P, Kania R (2018) Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss. Acta Otolaryngol 138(11):966–971. https://doi.org/10.1080/00016489.2018.1497805
Nakache G, Migirov L, Trommer S, Drendel M, Wolf M, Henkin Y (2015) Steroid-based treatments for patients with total sudden sensorineural hearing loss. Acta Otolaryngol 135(9):907–913. https://doi.org/10.3109/00016489.2015.1034881
Lee HY, Kim DK, Park YH, Cha WW, Kim GJ, Lee SH (2017) Prognostic factors for profound sudden idiopathic sensorineural hearing loss: a multicenter retrospective study. Eur Arch Otorhinolaryngol 274(1):143–149. https://doi.org/10.1007/s00405-016-4276-y
Stachler RJ, Chandrasekhar SS, Archer SM et al (2012) Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 146:S1–S35. https://doi.org/10.1177/0194599812436449
Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH (2008) Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 28(2):128–131
Roebuck J, Chang CY (2006) Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 135(2):276–279
Lee JB, Choi SJ (2015) Potential benefits of combination therapy as primary treatment for sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 154(2):328–334. https://doi.org/10.1177/0194599815615121
Chou YF, Chen PR, Kuo IJ, Yu SH, Wen YH, Wu HP (2013) Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss. Laryngoscope 123(9):2264–2269. https://doi.org/10.1002/lary.23909
Nosrati-Zarenoe R, Hultcrantz E (2012) Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otol Neurotol 33:523–531. https://doi.org/10.1097/MAO.0b013e31824b78da
Wang CT, Huang TW, Kuo SW, Cheng PW (2009) Correlation between audiovestibular function tests and hearing outcomes in severe to profound sudden sensorineural hearing loss. Ear Hear 30:110–114. https://doi.org/10.1097/AUD.0b013e318192655e
Cho CS, Choi YJ (2013) Prognostic factors in sudden sensorineural hearing loss: a retrospective study using interaction effects. Braz J Otorhinolaryngol 79(4):466–470. https://doi.org/10.5935/1808-8694.20130083
Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H (1994) Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 114:601–607
Pruszewicz A, Kruk-Zagajewska A, Szyfter W, Smolińska K (1983) Lipid levels in patients with sudden deafness of unknown aetiology. Audiology 22:63–72
Weng SF, Chen YS, Hsu CJ, Tseng FY (2005) Clinical features of sudden sensorineural hearing loss in diabetic patients. Laryngoscope 115:1676–1680
Funding
This work was supported by the Soonchunhyang University Research Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declares that they have no conflict of interest.
Ethical approval
The study was approved by the Institutional Review Board of Soonchunhyang University Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Choi, J.W., Lee, C.K., Kim, S.B. et al. Potential benefits of salvage intratympanic dexamethasone injection in profound idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 277, 2219–2227 (2020). https://doi.org/10.1007/s00405-020-05967-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-020-05967-z